glp-1 c elegans Mutant C. p53 Together with Gain-of-Function GLP-1/Notch Decreases UVC-Damage-Induced Germline Cell Death but Increases PARP Inhibitor-Induced Germline Cell Death Loss of the distal-proximal GLP-1/Notch

Apr 29, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Therapies, Type 2 Diabetes, Type 2 Diabetes 1,061 views The rise of oral GLP-1 medications is changing how clinicians approach type 2 diabetes treatment

Cell 165 , 16321643 (2016)

Long-term potentiation and functional synapse induction in developing hippocampus

Akkermansia+ helps support: microbiome diversity gut barrier function metabolic balance digestive health Maintaining a healthy microbiome is increasingly recognized as an important component of long-term wellness

Scenario analyses We performed a number of scenario analyses

There is no registered clinical trial of BPC-157 combined with TB-500